{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"What impact could protein stabilisation have for cancer patients?","description":"The latest episode of the DDW \u2018In Conversation With\u2019 series is available to listen to below. This week, Bruno Quinney speaks to Anthony Johnson and Matthew Fyfe from Outrun Therapeutics. Outrun is a biotech specialising in protein stabilisation, an approach being applied to treat HPV+ head and neck cancer. But what does protein stabilisation mean in practice? And what impact could the approach have for&amp;nbsp;cancer patients? You can listen below, or find The Drug Discovery World Podcast on&amp;nbsp;Spotify,&amp;nbsp;Google Play&amp;nbsp;and&amp;nbsp;Apple Podcasts. ","author_name":"The Drug Discovery World Podcast","author_url":"https:\/\/www.ddw-online.com\/","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41201755\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/201672895"}